Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK27.19B in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.

Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.04B 64.29M
Almirall SA ALM:SM EUR 1.32B 36.15M
Amarin AMRN:US USD 584.79M 10.54M
Amgen AMGN:US USD 5.35B 1.69B
Artemis Alpha ATS:LN GBP 103.67M 20.43M
AstraZeneca AZN:LN USD 35.79B 1.25B
Bayer BAYN:GR EUR 40.86B 2.09B
BioMarin Pharmaceutical BMRN:US USD 4.66B 55.89M
Bluebird Bio BLUE:US USD 354.74M 158.4M
Demant A/s WDH:DC DKK 8.56B 382M
Exelixis EXEL:US USD 2.56B 66.71M
Galapagos GLPG:NA EUR 2.56B 38.58M
Genmab GEN:DC DKK 27.19B 251M
GlaxoSmithKline GSK:LN GBP 11.82B 1.22B
GN Store Nord GN:DC DKK 6.63B 170M
Hikma Pharmaceutical HIK:LN USD 2.14B 41M
Immunogen IMGN:US USD 121.92M 33.91M
Insmed INSM:US USD -44653000 132.6M
Lonza Group LONN:SW CHF 10.6B 586M
Merck MRK:GR EUR 26.15B 222M
Novartis NOVN:VX USD 52.06B 7.28B
Regeneron Pharmaceuticals REGN:US USD 23.5B 831.2M
Roche Holding ROG:VX CHF 27.99B 2.8B
Seattle Genetics SGEN:US USD 2.72B 80.66M